BeStock  
Stocks › Medical Devices › AXGN

AxoGen AXGN

US equityMarket cap rank #2355Medical Devices
$55.75 −$0.60 (-1.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.10 +0.63%
Open$55.71
Prev close$56.35
Day range$55.03 – $56.91
Volume876.1K
Market cap$3.33B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership99.3%-1.35 pts vs. prior quarter
Institutions holding314+6 vs. prior quarter
Insider trades (recent)29 buys / 18 sellsNet buying
Short interest11.71% of floatDays to cover 3.3 · as of 30 Oct 2026
Short-sale volume share13.3%5-day average of daily volume

Short-sale volume as % of daily volume

5%13%20%28%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$33.59M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$32.4MSuper−$1.2MBig+$5.2MMid+$1.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 27.4% of shares outstanding.

Largest holders

  • BlackRock7.67%
  • Divisadero Street Capital Management, LP6.67%
  • First Light Asset Management, LLC4.60%
  • FMR4.42%
  • Vanguard Capital Management, LLC4.07%
  • Morgan Stanley3.00%
  • Artemis Investment Management LLP2.98%
  • Geode Capital Management, LLC2.76%

By investor type

  • Mutual Fund71.31%
  • Hedge Fund17.69%
  • Public Company6.34%
  • Individual/Insider1.91%
  • Private Company1.71%
  • Government Pension Fund1.05%
  • Insurance Company0.73%
  • VC/PE Fund0.41%

Reported short interest has risen from 6.26% to 11.71% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Divisadero Street Capital Management, LP Hedge Fund 2026/Q3 +3,813,367 6.7%
FMR Mutual Fund 2026/Q3 +1,415,423 4.4%
Stephens Investment Management Group, LLC Mutual Fund 2026/Q3 +871,949 1.9%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +426,372 0.7%
Artemis Investment Management LLP Mutual Fund 2026/Q3 +384,200 3.0%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +274,380 2.8%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +207,916 0.6%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +316,458 0.5%
Citadel Advisors LLC Hedge Fund 2026/Q3 +1,115,777 2.3%
Hood River Capital Management LLC Mutual Fund 2026/Q3 +1,067,072 1.8%
Artemis Investment Management LLP Mutual Fund 2026/Q3 +1,046,904 2.4%
RTW Investments, LP Hedge Fund 2026/Q3 +1,011,576 1.7%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +967,257 1.7%
UBS Asset Management Mutual Fund 2026/Q3 +740,743 1.6%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +623,098 1.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
1 Sep 2026 Joseph Tyndall Independent Director Automatic Disposition -3,500 $49.70 10,650
10 Aug 2026 Amy McBride-Wendell Lead Independent Director Derivative Exercise and Sale -13,353 $48.42 107,976
9 Aug 2026 Marc Began Executive VP, General Counsel, Secretary & Chief Compliance Officer Derivative Exercise and Sale -67,500 $47.35 50,135
6 Aug 2026 Kathy Weiler Independent Director Automatic Disposition -14,150 $45.30 –
23 Jun 2026 Paul Thomas Independent Chairperson Other Derivative Acquisition +5,579 – 5,579
23 Jun 2026 Amy McBride-Wendell Lead Independent Director Other Derivative Acquisition +4,392 – 4,392
23 Jun 2026 John Johnson Independent Director Other Derivative Acquisition +4,392 – 4,392
23 Jun 2026 Kathy Weiler Independent Director Other Derivative Acquisition +4,392 – 4,392
23 Jun 2026 Alan Levine Independent Director Other Derivative Acquisition +4,392 – 4,392
23 Jun 2026 William Burke Independent Director Other Derivative Acquisition +4,392 – 4,392
23 Jun 2026 Joseph Tyndall Independent Director Other Derivative Acquisition +4,392 – 4,392
18 Jun 2026 Paul Thomas Independent Chairperson Derivative Exercise and Retained +18,867 – 32,395
18 Jun 2026 Amy McBride-Wendell Lead Independent Director Derivative Exercise and Retained +14,150 – 107,976
18 Jun 2026 John Johnson Independent Director Derivative Exercise and Retained +14,150 – 14,150
18 Jun 2026 Kathy Weiler Independent Director Derivative Exercise and Retained +14,150 – 14,150
18 Jun 2026 Alan Levine Independent Director Derivative Exercise and Retained +14,150 – 50,893
18 Jun 2026 William Burke Independent Director Derivative Exercise and Retained +14,150 – 14,250
18 Jun 2026 Joseph Tyndall Independent Director Derivative Exercise and Retained +14,150 – 14,150
7 May 2026 Amy McBride-Wendell Lead Independent Director Derivative Exercise and Sale -1,647 $42.60 93,826
6 May 2026 John Johnson Independent Director Derivative Exercise and Sale -11,050 $43.26 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,991,930 11.7% 3.3
15 Oct 2026 5,123,544 8.7% 3.0
30 Sep 2026 4,697,283 8.0% 4.2
15 Sep 2026 4,055,417 6.9% 2.9
31 Aug 2026 3,809,350 7.1% 4.2
14 Aug 2026 3,365,313 6.3% 4.1

Discussion

No comments yet — be the first to weigh in on AXGN.

Sign in to join the discussion.

Scroll to Top